| Identification | More | [Name]
LITHIUM CITRATE TETRAHYDRATE | [CAS]
6080-58-6 | [Synonyms]
CITRIC ACID, 3LI, TETRAHYDRATE
CITRIC ACID TRILITHIUM SALT
CITRIC ACID, TRILITHIUM SALT TETRAHYDRATE
LITHIUM CITRATE
LITHIUM CITRATE TETRAHYDRATE
TRI-LITHIUM CITRATE TETRAHYDRATE
Lithium citrate tribasic tetrahydrate
Tri-LithiumCitrateGr(Tetrahydrate)
Lithium citrate tetrahydrate (tribasic)
Citric acid, trilithium salt tetrahydrate, pure, 98%
LITHIUM CITRATE REAGENT
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt, tetrahydrate
LITHIUMCITRATE,POWDER,REAGENT
Trilithiumcitrat, Tetrahydrat
tri-Lithium citrate anhydrous
Citric acid trilithium salt, Trilithium citrate tetrahydrate
Citric acid, trilithium salt tetrahydrate, 98%, pure | [EINECS(EC#)]
213-045-8 | [Molecular Formula]
C6H13Li3O11 | [MDL Number]
MFCD00150030 | [Molecular Weight]
281.98 | [MOL File]
6080-58-6.mol |
| Chemical Properties | Back Directory | [Appearance]
White crystalline powder | [Melting point ]
112 °C | [bulk density]
420kg/m3 | [density ]
1.64 at 20℃ | [storage temp. ]
2-8°C | [solubility ]
H2O: 1 M at 20 °C, clear, colorless
| [form ]
Fine Crystalline Powder | [color ]
White | [Odor]
Odorless | [PH]
8.0-9.5 (25℃, 1M in H2O) | [PH Range]
8.0 - 9.5 at 209.8 g/l at 25 °C | [Stability:]
Stable. Incompatible with strong oxidizing agents, reducing agents, bases. | [Water Solubility ]
209.8 g/l at 20 °C | [λmax]
λ: 260 nm Amax: 0.040
λ: 280 nm Amax: 0.016 | [Merck ]
13,5552 | [LogP]
-1.72--1.67 at 20-25℃ | [CAS DataBase Reference]
6080-58-6(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing . | [WGK Germany ]
1
| [F ]
3 | [HS Code ]
29181500 |
| Hazard Information | Back Directory | [Chemical Properties]
White crystalline powder | [Uses]
Lithium citrate is useful as a potential therapeutic for Canavan disease due to aspartoacylase deficiency or aminoacylase 2 deficiency. | [Uses]
alpha-glucosidase inhibitor, antidiabetic | [Application]
Citric acid trilithium salt tetrahydrate is a pharmaceutical structural material commonly used in the determination of amino acids by high-performance liquid chromatography gradient elution. | [Definition]
ChEBI: A hydrate that is the tetrahydrate form of lithium citrate. It is used as a source of lithium for the treatment of anxiety disorders, bipolar disorder, and depression. | [Brand name]
Lithonate (Solvay Pharmaceuticals). |
|
|